Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 221198
Company: INCYTE CORP

Products on NDA 221198

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ATEBRIOZ	ZILURGISERTIB	25MG	TABLET; ORAL	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 221198

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/25/2026	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/221198Orig1s000ltr.pdf